Gregory Klein

75 papers receiving 1.8k citations

Gregory Klein's Hit Papers

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease 2017 · 417 citations
4170+3+6Years since publication100200300400

Peers

Gregory Klein
Comparison fields: 5 of 107
  • Biological Psychiatry 88
  • Psychiatry and Mental health 491
  • Physiology 800
  • Neurology 166
  • Pharmacology 240
Replace Cynthia Evans with:
Cynthia Evans United States
J. Bohl Germany
Richard Batrla Switzerland
M. Köller United States
P. Jouanny France
Zhenyu Zhong China
Kensuke Sasaki Japan
Gwendlyn Kollmorgen Germany
Wei Qin China
Hannah Markham United Kingdom
Gregory Klein relative to Cynthia Evans United States Cynthia Evans's profile →
Citations per field
00.5×10×20×30.3×
Cynthia Evans · 1×
Citations per year

Countries citing papers authored by Gregory Klein

Since Specialization
Citations

This map shows the geographic impact of Gregory Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Klein more than expected).

Fields of papers citing papers by Gregory Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Klein. The network helps show where Gregory Klein may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregory Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory Klein Line = papers co-authored together Gregory Klein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Hit paper breakdown →
2017417
2 2019158
3 2020139
4 201493
5 202190
6 201688
7 202271
8
Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.
199163
9 200156
10 201855
11 199554
12 202145
13 200033
14 201833
15
Rejectability of virus-induced tumors and nonrejectability of spontaneous tumors: a lesson in contrasts.
197732
16 202230
17 202426
18
Human thymus-lymphoid tissue antigen and its presence in leukaemia and lymphoma.
197024
19
The Epstein-Barr virus (EBV) in the pathogenesis of posttransplant lymphoma.
198123
20 202321

About Gregory Klein

Gregory Klein is a scholar working on Physiology, Radiology, Nuclear Medicine and Imaging, Psychiatry and Mental health, Oncology and Economics and Econometrics, having authored 83 papers that have together received 1.8k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (21 papers), Dementia and Cognitive Impairment Research (14 papers), Medical Imaging Techniques and Applications (13 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Viral-associated cancers and disorders (7 papers), Statistical Methods in Clinical Trials (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Advanced MRI Techniques and Applications (5 papers). The work is most often cited by research in Biological Psychiatry (88 citations), Psychiatry and Mental health (491 citations), Physiology (800 citations), Neurology (166 citations) and Pharmacology (240 citations). Gregory Klein has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Paulo Fontoura, Paul Delmar, Carsten Hofmann, Mirjana Andjelković, Kaj Blennow, Merçé Boada, Rachelle S. Doody, Frederik Barkhof, Klas G. Wiman and Edilio Borroni. Their work appears in journals such as Alzheimer s & Dementia, JAMA Neurology, Neurology, Journal of Nuclear Medicine and Alzheimer s Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact